Oscar Health's Membership Growth Signals Strong Market Position
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 07 2025
0mins
Should l Buy OSCR?
Source: SeekingAlpha
Oscar Health's stock has reached a 5-day high, reflecting a positive market response.
The company reported a surge in membership to 3.4 million in 2026, up from 2 million at the end of 2025, indicating strong competitiveness in the individual market despite challenges from reduced subsidies. Additionally, Oscar anticipates operating income between $250 million and $450 million for 2026, suggesting potential for improved profitability. This growth in market share and positive outlook on profitability contribute to the stock's upward movement.
Oscar Health's innovative approach as a technology-driven health insurer positions it well for future growth, even amidst rising healthcare costs and market uncertainties.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy OSCR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on OSCR
Wall Street analysts forecast OSCR stock price to rise
8 Analyst Rating
1 Buy
4 Hold
3 Sell
Hold
Current: 14.640
Low
11.00
Averages
15.75
High
25.00
Current: 14.640
Low
11.00
Averages
15.75
High
25.00
About OSCR
Oscar Health, Inc. is a healthcare technology company built around a full stack technology platform. The Company's offerings include its insurance business and +Oscar Platform. Its health plans are offered in the individual market. The individual market primarily consists of policies purchased by individuals and families through health insurance marketplaces, established by the ACA and operated by the federal government, as well as other marketplaces operated by individual states. Individuals and families may also purchase policies in the individual market off-exchange. Employees whose employers have chosen to offer an Individual Coverage Health Reimbursement Arrangement (ICHRA) are also able to purchase its health plans. It offers health plans in the individual market under the five metal plan categories defined by the ACA: Catastrophic, Bronze, Silver, Gold, and Platinum. Through the +Oscar platform, the Company deploys its technology to help others throughout the healthcare system.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Oscar Health Stock Rises for Sixth Consecutive Day
- Medicare Reimbursement Increase: Oscar Health's stock surged 12.88% to close at $14.64 on Wednesday, following the announcement that Medicare Advantage reimbursement rates will rise to 2.48% in 2027 from just 0.09% in January, translating to over $13 billion in additional payments, significantly enhancing its financial outlook.
- Strong Market Performance: The stock's sixth consecutive day of gains reflects investor confidence in Oscar Health's growth potential, particularly in light of the increased reimbursement rates for Medicare plans, which are expected to bolster its competitive position in the market.
- Revenue Growth Target: Oscar Health is targeting a revenue increase of 60% to 62% for 2026, aiming for a range of $18.7 billion to $19 billion, compared to $11.7 billion in 2025, which will provide substantial funding for expansion and innovation initiatives.
- Earnings Report Schedule: The company is set to announce its first-quarter earnings before the market opens on May 6, with a conference call to discuss financial and operational highlights, and investor anticipation surrounding this report may further influence stock price movements.
See More
Oscar Health CEO Boosts Market Confidence with $12M Stock Purchase
- CEO Stock Purchase: Oscar Health's CEO Mark Bertolini purchased nearly $12 million worth of company shares on Wednesday morning, demonstrating strong confidence in the firm by acquiring 1 million shares at $11.92 each, totaling approximately $11.9 million.
- Increased Stake: This transaction increased Bertolini's stake in Oscar Health by 11%, bringing his total to 10.2 million shares, thereby reinforcing his control and trust in the company.
- Stock Price Surge: Following Bertolini's stock purchase, Oscar Health's shares rose about 7% on Tuesday, coinciding with the U.S. government's announcement of a 2.5% increase in reimbursements for Medicare Advantage health plans for 2027, surpassing previous proposals.
- Optimistic Market Outlook: Despite macroeconomic challenges anticipated in 2025, Oscar Health maintains an optimistic outlook, with expectations for significant price discovery in 2026, enhancing market confidence in its long-term growth potential.
See More
Oscar Health CEO's Share Purchase Sparks Market Attention
- CEO Share Purchase: Oscar Health's CEO Bertolini purchased nearly 1 million shares at $11.92 each this month, totaling $11.9 million, demonstrating confidence in the company's future and potentially boosting investor trust.
- Stock Price Surge: Following the CEO's purchase announcement, Oscar Health's shares jumped 7% in after-hours trading, indicating a positive market reaction to management's confidence, which may attract more investor interest.
- Optimistic Financial Outlook: Oscar Health expects total revenue to reach between $18.7 billion and $19.0 billion by 2026, with a medical loss ratio projected to drop to 82.4% to 83.4%, reflecting efforts to improve profitability and enhance market competitiveness.
- Divergent Analyst Ratings: Among the 10 analysts covering OSCR stock, 2 rated it as 'Strong Buy', 5 as 'Hold', and 3 as 'Sell' or 'Strong Sell', indicating mixed market sentiment regarding the company's prospects, which could influence investor decisions.
See More
Oscar Health Stock Down but Growth Potential Remains Strong
- Market Share Growth: Oscar Health's membership surged to 3.4 million in 2026, up from 2 million at the end of 2025, demonstrating strong competitiveness in the individual market despite challenges from reduced subsidies.
- Profitability Outlook: The company anticipates operating income between $250 million and $450 million for 2026, which, while a small margin of its projected $18.7 billion to $19 billion revenue, indicates potential for improved profitability.
- Low Market Valuation: With a current market cap of $3.2 billion, Oscar Health trades at less than 10 times the high end of its 2026 operating earnings guidance, suggesting the stock is undervalued and presents a good opportunity for long-term investors.
- Tech-Driven Competitive Edge: As a technology-forward health insurer, Oscar Health's innovations in customer experience allow it to stand out in a challenging environment, and despite rising healthcare costs, its market share continues to grow.
See More
Oscar Health Rapidly Gains Market Share Amidst Challenges
- Market Share Growth: Oscar Health's membership surged to 3.4 million after the 2026 enrollment period, up from 2 million at the end of 2025, demonstrating its strong competitive position despite challenges from reduced subsidies.
- Profitability Outlook: The company anticipates operating income between $250 million and $450 million for 2026, which, while a slim margin on its revenue expectations of $18.7 billion to $19 billion, indicates significant future growth potential.
- Stock Price Decline: Currently, Oscar Health's stock trades at a market cap of $3.2 billion, or less than 10 times the high end of its 2026 operating earnings guidance, suggesting the stock is undervalued and presents a good opportunity for long-term investors.
- Industry Pressures: Despite Oscar Health's success in gaining market share, the overall healthcare insurance sector has seen stock prices decline due to rising healthcare costs and uncertainty surrounding ACA subsidies, raising investor concerns.
See More
Geopolitical Conflict Impacts Oil Prices and Stock Market
- Market Volatility Intensifies: The geopolitical conflict in Iran has heightened concerns over oil prices and global inflation, leading the Nasdaq-100 index to drop over 10%, reflecting market anxiety about future economic conditions.
- Oscar Health Growth Potential: Oscar Health anticipates reaching 3.4 million members in 2026, and despite customer churn risks, the company expects to achieve $250 million to $450 million in operating income, demonstrating resilience in an economic downturn.
- Adyen Market Share Gains: Adyen, a global payment processor, has seen its stock drop over 50% from highs, yet its revenue grew 21% year-over-year in the second half of last year, with EBITDA margins at 55%, indicating strong long-term investment potential.
- Remitly Digital Transfer Advantage: Remitly Global is rapidly gaining market share in the foreign money transfer sector, with revenue increasing 26% year-over-year to $442 million and a record operating margin of 9%, showcasing the strength of its business model.
See More
Oscar Health Stock Rises for Sixth Consecutive Day
- Medicare Reimbursement Increase: Oscar Health's stock surged 12.88% to close at $14.64 on Wednesday, following the announcement that Medicare Advantage reimbursement rates will rise to 2.48% in 2027 from just 0.09% in January, translating to over $13 billion in additional payments, significantly enhancing its financial outlook.
- Strong Market Performance: The stock's sixth consecutive day of gains reflects investor confidence in Oscar Health's growth potential, particularly in light of the increased reimbursement rates for Medicare plans, which are expected to bolster its competitive position in the market.
- Revenue Growth Target: Oscar Health is targeting a revenue increase of 60% to 62% for 2026, aiming for a range of $18.7 billion to $19 billion, compared to $11.7 billion in 2025, which will provide substantial funding for expansion and innovation initiatives.
- Earnings Report Schedule: The company is set to announce its first-quarter earnings before the market opens on May 6, with a conference call to discuss financial and operational highlights, and investor anticipation surrounding this report may further influence stock price movements.
See More
Oscar Health CEO Boosts Market Confidence with $12M Stock Purchase
- CEO Stock Purchase: Oscar Health's CEO Mark Bertolini purchased nearly $12 million worth of company shares on Wednesday morning, demonstrating strong confidence in the firm by acquiring 1 million shares at $11.92 each, totaling approximately $11.9 million.
- Increased Stake: This transaction increased Bertolini's stake in Oscar Health by 11%, bringing his total to 10.2 million shares, thereby reinforcing his control and trust in the company.
- Stock Price Surge: Following Bertolini's stock purchase, Oscar Health's shares rose about 7% on Tuesday, coinciding with the U.S. government's announcement of a 2.5% increase in reimbursements for Medicare Advantage health plans for 2027, surpassing previous proposals.
- Optimistic Market Outlook: Despite macroeconomic challenges anticipated in 2025, Oscar Health maintains an optimistic outlook, with expectations for significant price discovery in 2026, enhancing market confidence in its long-term growth potential.
See More
Oscar Health CEO's Share Purchase Sparks Market Attention
- CEO Share Purchase: Oscar Health's CEO Bertolini purchased nearly 1 million shares at $11.92 each this month, totaling $11.9 million, demonstrating confidence in the company's future and potentially boosting investor trust.
- Stock Price Surge: Following the CEO's purchase announcement, Oscar Health's shares jumped 7% in after-hours trading, indicating a positive market reaction to management's confidence, which may attract more investor interest.
- Optimistic Financial Outlook: Oscar Health expects total revenue to reach between $18.7 billion and $19.0 billion by 2026, with a medical loss ratio projected to drop to 82.4% to 83.4%, reflecting efforts to improve profitability and enhance market competitiveness.
- Divergent Analyst Ratings: Among the 10 analysts covering OSCR stock, 2 rated it as 'Strong Buy', 5 as 'Hold', and 3 as 'Sell' or 'Strong Sell', indicating mixed market sentiment regarding the company's prospects, which could influence investor decisions.
See More
Oscar Health Stock Down but Growth Potential Remains Strong
- Market Share Growth: Oscar Health's membership surged to 3.4 million in 2026, up from 2 million at the end of 2025, demonstrating strong competitiveness in the individual market despite challenges from reduced subsidies.
- Profitability Outlook: The company anticipates operating income between $250 million and $450 million for 2026, which, while a small margin of its projected $18.7 billion to $19 billion revenue, indicates potential for improved profitability.
- Low Market Valuation: With a current market cap of $3.2 billion, Oscar Health trades at less than 10 times the high end of its 2026 operating earnings guidance, suggesting the stock is undervalued and presents a good opportunity for long-term investors.
- Tech-Driven Competitive Edge: As a technology-forward health insurer, Oscar Health's innovations in customer experience allow it to stand out in a challenging environment, and despite rising healthcare costs, its market share continues to grow.
See More
Oscar Health Rapidly Gains Market Share Amidst Challenges
- Market Share Growth: Oscar Health's membership surged to 3.4 million after the 2026 enrollment period, up from 2 million at the end of 2025, demonstrating its strong competitive position despite challenges from reduced subsidies.
- Profitability Outlook: The company anticipates operating income between $250 million and $450 million for 2026, which, while a slim margin on its revenue expectations of $18.7 billion to $19 billion, indicates significant future growth potential.
- Stock Price Decline: Currently, Oscar Health's stock trades at a market cap of $3.2 billion, or less than 10 times the high end of its 2026 operating earnings guidance, suggesting the stock is undervalued and presents a good opportunity for long-term investors.
- Industry Pressures: Despite Oscar Health's success in gaining market share, the overall healthcare insurance sector has seen stock prices decline due to rising healthcare costs and uncertainty surrounding ACA subsidies, raising investor concerns.
See More
Geopolitical Conflict Impacts Oil Prices and Stock Market
- Market Volatility Intensifies: The geopolitical conflict in Iran has heightened concerns over oil prices and global inflation, leading the Nasdaq-100 index to drop over 10%, reflecting market anxiety about future economic conditions.
- Oscar Health Growth Potential: Oscar Health anticipates reaching 3.4 million members in 2026, and despite customer churn risks, the company expects to achieve $250 million to $450 million in operating income, demonstrating resilience in an economic downturn.
- Adyen Market Share Gains: Adyen, a global payment processor, has seen its stock drop over 50% from highs, yet its revenue grew 21% year-over-year in the second half of last year, with EBITDA margins at 55%, indicating strong long-term investment potential.
- Remitly Digital Transfer Advantage: Remitly Global is rapidly gaining market share in the foreign money transfer sector, with revenue increasing 26% year-over-year to $442 million and a record operating margin of 9%, showcasing the strength of its business model.
See More
